GLU-xx Formulations in Individuals With Impaired Glucose Tolerance

NCT01468376 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
17
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor company was acquired and new owner chose not to proceed with clinical study

Conditions

Interventions

Sponsor

Afexa Life Sciences Inc